Search

Your search keyword '"Nakagawa, Tomoo"' showing total 459 results

Search Constraints

Start Over You searched for: Author "Nakagawa, Tomoo" Remove constraint Author: "Nakagawa, Tomoo"
459 results on '"Nakagawa, Tomoo"'

Search Results

1. Treatment strategy changes for inflammatory bowel diseases in biologic era: results from a multicenter cohort in Japan, Far East 1000

4. The long-term effect of biologics in patients with ulcerative colitis emerging from a large Japanese cohort

5. AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study

6. Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke

8. Clinical and Pharmacokinetic Factors Associated With Adalimumab-Induced Mucosal Healing in Patients With Crohn’s Disease

9. Immunomodulator-associated Epstein–Barr virus-positive mucocutaneous ulcer in a patient with refractory Crohn’s disease

10. NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study

12. Clinical Features Focusing on Extraintestinal Manifestations in Japanese Patients with Inflammatory Bowel Diseases: Far East 1000

15. AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study

18. Significance of measurement of serum trough level and anti‐drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohnʼs disease: a subanalysis of the DIAMOND trial

27. Biologics did not reduce surgery rate but prolonged remission duration in patients with ulcerative colitis: analysis of a large retrospective Japanese cohort

28. Impact of the COVID-19 pandemic on a trauma center of a university hospital in Japan

29. Clinical Characteristics of Esophageal Motility Disorders in Patients With Heartburn

32. Additional file 1 of Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke

34. Comprehensive mutational analysis of background mucosa in patients with Lugol‐voiding lesions

35. Efficacy and Safety of Biosimilar Infliximab in Bio-naïve Patients With Crohn’s Disease

45. The Efficacy of Linked Color Imaging in the Endoscopic Diagnosis of Barrett’s Esophagus and Esophageal Adenocarcinoma

49. Interferon‑γ induced PD‑L1 expression and soluble PD‑L1 production in gastric cancer

50. Impact of ineffective esophageal motility on chemical clearance in patients with gastroesophageal reflux symptoms

Catalog

Books, media, physical & digital resources